StockData
BioCorRx Inc. logo

BioCorRx Inc. (BICX) stock

BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$0.25+0.00 (0.00%)

Close on Oct 19, 2026Market cap $7.30MP/E –Yield –

BioCorRx total assets

Total assets on the balance sheet at the end of each period.

BioCorRx's total assets was $1.91M at Jun 30, 2026. For fiscal 2025 it was $2.15M, up 456.4% from the year before. Over ten years it grew 4.3% a year on average. The highest annual figure on record is $5.08M in fiscal 2012.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.15M+456.4%
FY2024Dec 31, 2024$385.94K-0.8%
FY2023Dec 31, 2023$388.89K-49.3%
FY2022Dec 31, 2022$766.59K-6.5%
FY2021Dec 31, 2021$819.98K-55.1%
FY2020Dec 31, 2020$1.83M-53.5%
FY2019Dec 31, 2019$3.93M+526.1%
FY2018Dec 31, 2018$628.22K+85.4%
FY2017Dec 31, 2017$338.90K-28.0%
FY2016Dec 31, 2016$470.38K-66.5%
FY2015Dec 31, 2015$1.41M-65.6%
FY2014Dec 31, 2014$4.08M-7.7%
FY2013Dec 31, 2013$4.43M-12.9%
FY2012Dec 31, 2012$5.08M+850.8%
FY2011Dec 31, 2011$534.62K-86.8%
FY2010Dec 31, 2010$4.06M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.91M-71.4%
Q1 FY2026Mar 31, 2026$2.32M-65.8%
Q4 FY2025Dec 31, 2025$2.15M+456.4%
Q3 FY2025Sep 30, 2025$7.53M+1070.6%
Q2 FY2025Jun 30, 2025$6.68M+1296.1%
Q1 FY2025Mar 31, 2025$6.80M+2042.5%
Q4 FY2024Dec 31, 2024$385.94K-0.8%
Q3 FY2024Sep 30, 2024$643.57K+20.4%
Q2 FY2024Jun 30, 2024$478.54K-36.8%
Q1 FY2024Mar 31, 2024$317.44K-55.2%
Q4 FY2023Dec 31, 2023$388.89K-49.3%
Q3 FY2023Sep 30, 2023$534.45K-53.3%
Q2 FY2023Jun 30, 2023$756.76K-7.7%
Q1 FY2023Mar 31, 2023$709.16K-55.3%
Q4 FY2022Dec 31, 2022$766.59K-72.7%
Q1 FY2022Mar 31, 2022$1.14M-37.4%
Q4 FY2021Dec 31, 2021$819.98K-66.4%
Q2 FY2021Sep 30, 2021$1.59M-55.2%
Q1 FY2021Mar 31, 2021$2.81M-35.6%
Q4 FY2020Dec 31, 2020$1.83M-53.5%
Q3 FY2020Sep 30, 2020$2.44M-45.7%
Q2 FY2020Jun 30, 2020$3.54M-35.8%
Q1 FY2020Mar 31, 2020$4.36M+817.2%
Q4 FY2019Dec 31, 2019$3.93M+526.1%
Q3 FY2019Sep 30, 2019$4.50M+665.4%
Q2 FY2019Jun 30, 2019$5.51M+496.9%
Q1 FY2019Mar 31, 2019$475.71K+52.1%
Q4 FY2018Dec 31, 2018$628.22K+85.4%
Q3 FY2018Sep 30, 2018$587.57K-11.0%
Q2 FY2018Jun 30, 2018$923.36K-26.5%
Q1 FY2018Mar 31, 2018$312.69K-84.9%
Q4 FY2017Dec 31, 2017$338.90K-28.0%
Q3 FY2017Sep 30, 2017$660.37K+4.8%
Q2 FY2017Jun 30, 2017$1.26M-20.6%
Q1 FY2017Mar 31, 2017$2.07M+638.4%
Q4 FY2016Dec 31, 2016$470.38K-66.5%
Q3 FY2016Sep 30, 2016$629.89K–
Q2 FY2016Jun 30, 2016$1.58M–
Q1 FY2016Mar 31, 2016$280.27K–
Q4 FY2015Dec 31, 2015$1.41M–

More BioCorRx figures

See a number that looks wrong?